OMADACYCLINE

OMADACYCLINE was reported 1716 times

OMADACYCLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MESOTHELIOMA MALIGNANT RECURRENT 1 0.1429
1 HYDROXYAPATITE CRYSTAL DEPOSITION DISEASE 1 0.1111
2 CUTANEOUS SPOROTRICHOSIS 3 0.0625
3 MYCOBACTERIUM ABSCESSUS INFECTION 24 0.0336
4 GASTRIC BANDING REVERSAL 1 0.0303
5 MEDICAL DEVICE SITE CALCIFICATION 1 0.0303
6 ARTHROPOD-BORNE DISEASE 1 0.0286
7 BILE ACIDS INCREASED 5 0.0282
8 ANTIBIOTIC ASSOCIATED COLITIS 1 0.0270
9 IMPLANT SITE NODULE 1 0.0238
10 RAPIDLY PROGRESSIVE OSTEOARTHRITIS 1 0.0233
11 ATYPICAL MYCOBACTERIUM TEST POSITIVE 2 0.0206
12 DRUG DOSE TITRATION NOT PERFORMED 36 0.0196
13 GENITAL INFECTION MALE 1 0.0175
14 INFUSION SITE PHLEBITIS 4 0.0175
15 INTERCOSTAL NEURALGIA 3 0.0169
16 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2 0.0167
17 DISSEMINATED HERPES SIMPLEX 1 0.0135
18 INFECTIVE EXACERBATION OF BRONCHIECTASIS 4 0.0130
19 KERATOSIS FOLLICULAR 1 0.0128
20 INTRACARDIAC PRESSURE INCREASED 1 0.0114
21 PORTAL VEIN DILATATION 1 0.0112
22 CARDIOLIPIN ANTIBODY POSITIVE 2 0.0109
23 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 5 0.0100
24 MEDICAL DEVICE SITE THROMBOSIS 1 0.0097
25 OVERGROWTH FUNGAL 1 0.0097
26 PEPTOSTREPTOCOCCUS INFECTION 1 0.0095
27 MYCOBACTERIUM CHELONAE INFECTION 7 0.0095
28 TOOTH DISCOLOURATION 27 0.0092
29 GLUTAMATE DEHYDROGENASE INCREASED 1 0.0090
30 ICHTHYOSIS 2 0.0079
31 MYCOBACTERIUM AVIUM COMPLEX INFECTION 21 0.0078
32 TRICHOGLOSSIA 3 0.0073
33 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
34 RASH FOLLICULAR 1 0.0065
35 DACRYOCYSTITIS 1 0.0065
36 PROCEDURAL PNEUMOTHORAX 1 0.0065
37 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 1 0.0065
38 ANAL SKIN TAGS 1 0.0061
39 RESPIRATORY TRACT INFECTION FUNGAL 3 0.0057
40 BASE EXCESS DECREASED 1 0.0056
41 AUTOSCOPY 3 0.0056
42 PENICILLIUM INFECTION 1 0.0056
43 ORAL BACTERIAL INFECTION 1 0.0055
44 BLOOD BILIRUBIN UNCONJUGATED INCREASED 4 0.0055
45 CUTANEOUS TUBERCULOSIS 1 0.0055
46 PICKWICKIAN SYNDROME 1 0.0053
47 CHEST TUBE INSERTION 1 0.0053
48 VANCOMYCIN INFUSION REACTION 2 0.0053
49 BLOOD FIBRINOGEN DECREASED 6 0.0053
50 EYELID RASH 5 0.0051
51 DYSBIOSIS 4 0.0049
52 MYCOBACTERIUM TEST POSITIVE 1 0.0049
53 PSOAS ABSCESS 3 0.0048
54 INFLUENZA VIRUS TEST POSITIVE 1 0.0047
55 MYCOBACTERIAL INFECTION 8 0.0046
56 MUSCLE OEDEMA 1 0.0046
57 ACUTE ON CHRONIC LIVER FAILURE 1 0.0046
58 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0045
59 INCORRECT PRODUCT ADMINISTRATION DURATION 95 0.0044
60 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
61 BILIRUBIN CONJUGATED INCREASED 10 0.0043
62 LARYNX IRRITATION 1 0.0043
63 AMOEBIASIS 1 0.0043
64 PERIPHERAL VEIN THROMBOSIS 1 0.0042
65 GRANULOMATOUS DERMATITIS 1 0.0041
66 DEPENDENCE ON OXYGEN THERAPY 2 0.0041
67 KERATOSIS PILARIS 1 0.0040
68 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 2 0.0040
69 LEFT VENTRICULAR ENLARGEMENT 1 0.0039
70 OTOTOXICITY 7 0.0038
71 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 1 0.0037
72 ATRIAL ENLARGEMENT 1 0.0037
73 SPINAL CORD ABSCESS 1 0.0037
74 TONGUE ERYTHEMA 3 0.0036
75 HYPERTENSIVE URGENCY 2 0.0036
76 MEDICAL DEVICE SITE HAEMORRHAGE 1 0.0035
77 GINGIVAL ERYTHEMA 3 0.0035
78 WOUND INFECTION STAPHYLOCOCCAL 6 0.0035
79 EPIDIDYMITIS 4 0.0034
80 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
81 CORNEA VERTICILLATA 1 0.0033
82 SPUTUM INCREASED 7 0.0032
83 CHRONIC HEPATITIS B 1 0.0032
84 INCREASED VISCOSITY OF BRONCHIAL SECRETION 2 0.0031
85 PROSTATE INFECTION 3 0.0031
86 NOROVIRUS TEST POSITIVE 1 0.0031
87 SINUS ARRHYTHMIA 4 0.0031
88 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
89 GAS GANGRENE 1 0.0029
90 INFUSION SITE RASH 4 0.0029
91 RESPIRATORY TRACT IRRITATION 3 0.0029
92 CHRONIC RESPIRATORY DISEASE 1 0.0028
93 JARISCH-HERXHEIMER REACTION 2 0.0028
94 PRODUCT DESIGN ISSUE 2 0.0028
95 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
96 BRONCHIECTASIS 18 0.0027
97 TENDON DISCOMFORT 2 0.0026
98 CREATINE KINASE INCREASED 2 0.0026
99 DEBRIDEMENT 2 0.0026
100 LYMPHANGITIS 2 0.0025
101 CAT SCRATCH DISEASE 1 0.0025
102 SKIN BACTERIAL INFECTION 2 0.0025
103 SPUTUM CULTURE POSITIVE 2 0.0025
104 BONE ABSCESS 1 0.0025
105 INFUSION 1 0.0024
106 AMAUROSIS 2 0.0024
107 NAIL BED DISORDER 1 0.0023
108 OESOPHAGEAL DILATATION 1 0.0023
109 CATHETER SITE RASH 1 0.0022
110 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
111 INCISION SITE ERYTHEMA 1 0.0022
112 ATYPICAL MYCOBACTERIAL INFECTION 3 0.0021
113 BLOOD URIC ACID DECREASED 1 0.0021
114 CEREBRAL ARTERY STENOSIS 1 0.0020
115 SPUTUM RETENTION 2 0.0020
116 HYPOFIBRINOGENAEMIA 2 0.0020
117 DERMATITIS INFECTED 1 0.0020
118 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
119 MYOGLOBIN BLOOD INCREASED 3 0.0020
120 MEDICAL DEVICE CHANGE 1 0.0019
121 PATHOGEN RESISTANCE 17 0.0019
122 GINGIVAL DISCOLOURATION 1 0.0019
123 ACINETOBACTER INFECTION 2 0.0018
124 MACULE 5 0.0018
125 NAIL DYSTROPHY 1 0.0018
126 WOUND SECRETION 7 0.0018
127 SINUS POLYP 1 0.0017
128 PULMONARY PAIN 5 0.0017
129 DEVICE MAINTENANCE ISSUE 1 0.0017
130 PNEUMOCOCCAL INFECTION 1 0.0017
131 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
132 POSTOPERATIVE THROMBOSIS 1 0.0017
133 OSTEOMYELITIS CHRONIC 1 0.0016
134 HYPERCHLORAEMIA 1 0.0016
135 NEUROPATHIC ARTHROPATHY 1 0.0015
136 CELLULITIS STAPHYLOCOCCAL 1 0.0015
137 DRUG RESISTANCE 39 0.0015
138 SKIN HYPERPIGMENTATION 13 0.0015
139 POSTOPERATIVE ABSCESS 1 0.0015
140 VULVOVAGINAL CANDIDIASIS 2 0.0015
141 SCEDOSPORIUM INFECTION 1 0.0014
142 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
143 FORCED EXPIRATORY VOLUME DECREASED 4 0.0014
144 PCO2 INCREASED 1 0.0014
145 TONGUE DISCOLOURATION 6 0.0014
146 SKIN MASS 9 0.0013
147 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
148 LYMPH NODE TUBERCULOSIS 1 0.0013
149 SKIN STRIAE 2 0.0013
150 FEAR OF DEATH 3 0.0013
151 OESOPHAGEAL DISCOMFORT 1 0.0013
152 PROSTATITIS 4 0.0013
153 PNEUMONIA PSEUDOMONAL 2 0.0013
154 QRS AXIS ABNORMAL 1 0.0013
155 EXTRADURAL ABSCESS 1 0.0013
156 IMPLANT SITE EXTRAVASATION 1 0.0013
157 EXCESSIVE GRANULATION TISSUE 1 0.0012
158 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
159 LUNG OPERATION 1 0.0012
160 INFECTED BITE 1 0.0012
161 DEAFNESS BILATERAL 2 0.0012
162 OCULAR ICTERUS 5 0.0012
163 PULMONARY CAVITATION 1 0.0011
164 HYPERTRANSAMINASAEMIA 8 0.0011
165 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
166 SPINAL CORD NEOPLASM 1 0.0011
167 CYTOPENIA 14 0.0011
168 PULMONARY FUNCTION TEST DECREASED 5 0.0011
169 LUNG OPACITY 3 0.0011
170 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
171 HEPATIC FUNCTION ABNORMAL 42 0.0011
172 ARTERIOVENOUS MALFORMATION 1 0.0011
173 ASPARTATE AMINOTRANSFERASE INCREASED 57 0.0011
174 PROTHROMBIN LEVEL DECREASED 1 0.0011
175 HYPERCOAGULATION 2 0.0010
176 DISCOLOURED VOMIT 1 0.0010
177 VOMITING PROJECTILE 3 0.0010
178 ANTIBIOTIC THERAPY 1 0.0010
179 CONCOMITANT DISEASE PROGRESSION 2 0.0010
180 OROPHARYNGEAL SWELLING 1 0.0010
181 RENAL TRANSPLANT FAILURE 1 0.0010
182 GASTRECTOMY 1 0.0010
183 PAPULE 7 0.0010
184 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
185 CAROTID ARTERIOSCLEROSIS 1 0.0010
186 SKIN INDURATION 2 0.0010
187 POST LUMBAR PUNCTURE SYNDROME 1 0.0010
188 SWELLING OF EYELID 6 0.0010
189 NON-CARDIAC CHEST PAIN 3 0.0009
190 AMAUROSIS FUGAX 1 0.0009
191 PSEUDOMEMBRANOUS COLITIS 2 0.0009
192 PULMONARY SARCOIDOSIS 1 0.0009
193 MYOCARDIAL INJURY 1 0.0009
194 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 48 0.0009
195 DERMATITIS ALLERGIC 11 0.0009
196 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
197 PO2 DECREASED 1 0.0009
198 PRURITUS ALLERGIC 1 0.0009
199 LIP ULCERATION 1 0.0009
200 YELLOW SKIN 4 0.0009
201 LUNG TRANSPLANT 3 0.0008
202 ACUTE LUNG INJURY 1 0.0008
203 DEAFNESS 22 0.0008
204 EOSINOPHIL COUNT INCREASED 7 0.0008
205 OXYGEN CONSUMPTION INCREASED 2 0.0008
206 BRONCHIAL HYPERREACTIVITY 1 0.0008
207 CHRONIC RESPIRATORY FAILURE 1 0.0008
208 PENILE SWELLING 1 0.0008
209 PSEUDOMONAS INFECTION 7 0.0008
210 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
211 AMYLASE INCREASED 3 0.0008
212 BLOOD UREA DECREASED 1 0.0008
213 ALLERGY TO CHEMICALS 1 0.0008
214 AMPUTATION 1 0.0008
215 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
216 PROTEIN TOTAL DECREASED 3 0.0008
217 SEROMA 1 0.0008
218 LIP HAEMORRHAGE 1 0.0008
219 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
220 BLOOD BILIRUBIN INCREASED 21 0.0008
221 PNEUMONIA BACTERIAL 7 0.0008
222 SKIN DISCOLOURATION 35 0.0008
223 PNEUMONIA FUNGAL 3 0.0008
224 BLOOD ALBUMIN DECREASED 6 0.0008
225 HAEMOPTYSIS 21 0.0008
226 FUNGAL SKIN INFECTION 3 0.0007
227 EAR CONGESTION 2 0.0007
228 SKIN WRINKLING 2 0.0007
229 SIALOADENITIS 1 0.0007
230 ARTHRITIS BACTERIAL 3 0.0007
231 RHONCHI 1 0.0007
232 CYSTIC FIBROSIS 4 0.0007
233 DISCHARGE 1 0.0007
234 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
235 DIABETIC FOOT INFECTION 1 0.0007
236 AUDITORY DISORDER 1 0.0007
237 BLOOD ELECTROLYTES DECREASED 1 0.0007
238 RESPIRATORY SYMPTOM 2 0.0007
239 TINNITUS 32 0.0007
240 SKIN ATROPHY 4 0.0007
241 FOOT AMPUTATION 1 0.0007
242 BILIARY DILATATION 1 0.0007
243 DRUG ERUPTION 12 0.0007
244 CHOLANGIOCARCINOMA 1 0.0007
245 HYPERCAPNIA 2 0.0007
246 SMALL CELL LUNG CANCER 1 0.0007
247 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
248 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
249 PALLIATIVE CARE 1 0.0007
250 MULTIPLE-DRUG RESISTANCE 2 0.0006
251 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
252 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
253 BLOOD BLISTER 2 0.0006
254 SPUTUM DISCOLOURED 6 0.0006
255 ORTHOPNOEA 2 0.0006
256 PNEUMONIA LEGIONELLA 1 0.0006
257 METABOLIC ALKALOSIS 1 0.0006
258 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
259 SKIN EROSION 2 0.0006
260 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
261 OPTIC ATROPHY 1 0.0006
262 DEAFNESS NEUROSENSORY 2 0.0006
263 OSTEOMYELITIS 11 0.0006
264 LISTLESS 2 0.0006
265 POOR QUALITY SLEEP 13 0.0006
266 RESUSCITATION 1 0.0006
267 MEDICAL PROCEDURE 1 0.0006
268 LYME DISEASE 2 0.0006
269 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
270 DYSPHORIA 3 0.0006
271 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
272 LAZINESS 1 0.0006
273 BLOOD PH DECREASED 1 0.0006
274 APHONIA 8 0.0006
275 BRONCHIOLITIS 2 0.0006
276 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
277 FIBRIN D DIMER INCREASED 2 0.0006
278 JUGULAR VEIN THROMBOSIS 1 0.0006
279 SECRETION DISCHARGE 7 0.0006
280 PNEUMOMEDIASTINUM 1 0.0006
281 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
282 FAECES SOFT 4 0.0005
283 SOFT TISSUE INFECTION 1 0.0005
284 DEAFNESS UNILATERAL 3 0.0005
285 PNEUMONIA KLEBSIELLA 1 0.0005
286 DISORGANISED SPEECH 1 0.0005
287 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
288 LYMPH NODE PAIN 1 0.0005
289 CHRONIC SINUSITIS 2 0.0005
290 INTERVERTEBRAL DISCITIS 1 0.0005
291 PARANASAL SINUS DISCOMFORT 2 0.0005
292 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
293 LIPASE INCREASED 4 0.0005
294 HEPATIC MASS 1 0.0005
295 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
296 OFF LABEL USE 454 0.0005
297 RALES 3 0.0005
298 REHABILITATION THERAPY 2 0.0005
299 SKIN WARM 3 0.0005
300 EARLY SATIETY 1 0.0005
301 LIVER FUNCTION TEST INCREASED 11 0.0005
302 NASAL SEPTUM DEVIATION 1 0.0005
303 HYPOGEUSIA 1 0.0005
304 HYPERAEMIA 1 0.0005
305 OESOPHAGEAL PAIN 2 0.0005
306 FURUNCLE 4 0.0005
307 THERAPY INTERRUPTED 36 0.0005
308 NIPPLE PAIN 1 0.0005
309 RENAL MASS 1 0.0005
310 PRODUCTIVE COUGH 23 0.0005
311 SKIN LESION 13 0.0005
312 PHARYNGEAL ERYTHEMA 1 0.0005
313 TONGUE DISCOMFORT 2 0.0005
314 HEPATIC ENZYME INCREASED 32 0.0005
315 PURULENT DISCHARGE 2 0.0005
316 TEARFULNESS 2 0.0005
317 DYSPHONIA 27 0.0005
318 HERPES SIMPLEX 3 0.0005
319 TENDON DISORDER 3 0.0005
320 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
321 PURPURA 4 0.0005
322 TRANSAMINASES INCREASED 10 0.0004
323 PANCREATITIS ACUTE 10 0.0004
324 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
325 SUSPECTED OFF LABEL USE 2 0.0004
326 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
327 RASH ERYTHEMATOUS 21 0.0004
328 HAEMATOCRIT INCREASED 1 0.0004
329 INTERNAL HAEMORRHAGE 5 0.0004
330 PANCREATITIS NECROTISING 1 0.0004
331 ARTHRITIS INFECTIVE 2 0.0004
332 PERFORMANCE STATUS DECREASED 2 0.0004
333 CONTRAST MEDIA REACTION 1 0.0004
334 LONG QT SYNDROME 1 0.0004
335 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
336 BREATH SOUNDS ABNORMAL 2 0.0004
337 HYPERVOLAEMIA 2 0.0004
338 GENERALISED OEDEMA 5 0.0004
339 HOSPITALISATION 62 0.0004
340 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
341 GASTROINTESTINAL TUBE INSERTION 1 0.0004
342 EOSINOPHILIA 7 0.0004
343 DIABETIC COMPLICATION 1 0.0004
344 INSURANCE ISSUE 6 0.0004
345 AORTIC ARTERIOSCLEROSIS 1 0.0004
346 RASH PRURITIC 21 0.0004
347 INTENTIONAL DOSE OMISSION 11 0.0004
348 UNEVALUABLE EVENT 29 0.0004
349 RESPIRATORY TRACT CONGESTION 6 0.0004
350 ULCER 6 0.0004
351 PRODUCT CLEANING INADEQUATE 1 0.0004
352 CHEILITIS 2 0.0004
353 ABDOMINAL RIGIDITY 1 0.0004
354 GASTRIC PERFORATION 1 0.0004
355 ASPIRATION 4 0.0004
356 CHOLESTASIS 7 0.0004
357 RED BLOOD CELL COUNT INCREASED 1 0.0004
358 HYPERKERATOSIS 2 0.0004
359 PLEURITIC PAIN 1 0.0004
360 RASH MORBILLIFORM 1 0.0004
361 INTRACRANIAL PRESSURE INCREASED 2 0.0004
362 RASH PAPULAR 8 0.0004
363 SKIN INFECTION 4 0.0004
364 DRUG TOLERANCE DECREASED 1 0.0004
365 SKIN HYPERTROPHY 1 0.0004
366 NECK MASS 1 0.0004
367 VOMITING 166 0.0004
368 MUSCLE STRAIN 3 0.0003
369 MOUTH SWELLING 2 0.0003
370 TASTE DISORDER 7 0.0003
371 NAUSEA 268 0.0003
372 HEPATITIS FULMINANT 1 0.0003
373 PROTHROMBIN TIME PROLONGED 2 0.0003
374 METABOLIC ENCEPHALOPATHY 1 0.0003
375 MIXED LIVER INJURY 1 0.0003
376 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
377 PLATELET COUNT ABNORMAL 2 0.0003
378 LOCALISED INFECTION 8 0.0003
379 EMERGENCY CARE 1 0.0003
380 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
381 PENILE PAIN 1 0.0003
382 RETCHING 7 0.0003
383 VULVOVAGINAL BURNING SENSATION 2 0.0003
384 LUNG DISORDER 16 0.0003
385 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
386 BLISTER 18 0.0003
387 OXYGEN SATURATION DECREASED 18 0.0003
388 BLOOD SODIUM DECREASED 6 0.0003
389 EYE INFLAMMATION 3 0.0003
390 PNEUMONIA VIRAL 1 0.0003
391 NIGHT SWEATS 10 0.0003
392 ASPERGILLUS INFECTION 2 0.0003
393 HYPOGAMMAGLOBULINAEMIA 2 0.0003
394 PULMONARY CONGESTION 4 0.0003
395 INCORRECT DOSE ADMINISTERED 69 0.0003
396 SKIN INJURY 1 0.0003
397 PEPTIC ULCER 1 0.0003
398 CARDIAC FAILURE ACUTE 2 0.0003
399 FUNGAL INFECTION 10 0.0003
400 PROSTATE CANCER METASTATIC 1 0.0003
401 CANDIDA INFECTION 5 0.0003
402 DRY THROAT 3 0.0003
403 DRUG LEVEL DECREASED 3 0.0003
404 NEUROPATHY PERIPHERAL 28 0.0003
405 VENTRICULAR EXTRASYSTOLES 3 0.0003
406 GRANULOMA 1 0.0003
407 NECROTISING FASCIITIS 1 0.0003
408 HAEMORRHAGIC DIATHESIS 1 0.0003
409 BRONCHOSPASM 4 0.0003
410 HYPOACUSIS 12 0.0003
411 PANIC REACTION 2 0.0003
412 TONGUE DISORDER 2 0.0003
413 SKIN LACERATION 3 0.0003
414 BLOOD CREATININE INCREASED 18 0.0003
415 LIP SWELLING 9 0.0003
416 ARTHROPOD BITE 2 0.0003
417 DRUG INTOLERANCE 26 0.0003
418 NEURODERMATITIS 1 0.0003
419 ABDOMINAL DISCOMFORT 45 0.0003
420 SCAB 3 0.0003
421 GASTRIC INFECTION 1 0.0003
422 OESOPHAGEAL ULCER 1 0.0003
423 ACUTE RESPIRATORY FAILURE 5 0.0003
424 CELLULITIS 13 0.0003
425 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
426 RHINOVIRUS INFECTION 1 0.0003
427 PRODUCT USE COMPLAINT 4 0.0003
428 SINUS DISORDER 5 0.0003
429 NASAL DISCOMFORT 2 0.0003
430 CHOLECYSTITIS 3 0.0003
431 OBSTRUCTION 1 0.0003
432 MYASTHENIA GRAVIS 2 0.0002
433 FRUSTRATION TOLERANCE DECREASED 2 0.0002
434 PRODUCT ADMINISTRATION ERROR 5 0.0002
435 NOCTURIA 3 0.0002
436 APPLICATION SITE DISCOLOURATION 1 0.0002
437 LIVER INJURY 6 0.0002
438 POLYURIA 2 0.0002
439 LEG AMPUTATION 1 0.0002
440 STAPHYLOCOCCAL INFECTION 8 0.0002
441 HYPERSENSITIVITY 45 0.0002
442 DYSGEUSIA 18 0.0002
443 AGEUSIA 6 0.0002
444 LEUKOPENIA 12 0.0002
445 HALLUCINATIONS, MIXED 1 0.0002
446 HYPERPYREXIA 1 0.0002
447 MUSCLE FATIGUE 1 0.0002
448 POOR PERIPHERAL CIRCULATION 1 0.0002
449 ABSCESS LIMB 1 0.0002
450 HEPATIC PAIN 1 0.0002
451 PRODUCT DISPENSING ISSUE 1 0.0002
452 PRODUCT CONTAINER ISSUE 2 0.0002
453 CHAPPED LIPS 1 0.0002
454 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
455 MELANOCYTIC NAEVUS 1 0.0002
456 IMMUNE SYSTEM DISORDER 3 0.0002
457 PRODUCT COMMUNICATION ISSUE 2 0.0002
458 LUNG INFILTRATION 2 0.0002
459 BLOOD CREATINE INCREASED 1 0.0002
460 RESPIRATORY RATE INCREASED 2 0.0002
461 RASH MACULO-PAPULAR 5 0.0002
462 CHEST DISCOMFORT 23 0.0002
463 HEPATOTOXICITY 5 0.0002
464 GASTROINTESTINAL INFECTION 2 0.0002
465 TACHYPNOEA 3 0.0002
466 EAR DISORDER 1 0.0002
467 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
468 RETINAL DETACHMENT 2 0.0002
469 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
470 ORAL DISCOMFORT 3 0.0002
471 PRODUCT DISTRIBUTION ISSUE 2 0.0002
472 HYPOMAGNESAEMIA 3 0.0002
473 CARPAL TUNNEL SYNDROME 3 0.0002
474 HYPONATRAEMIA 12 0.0002
475 SKIN TIGHTNESS 1 0.0002
476 SQUAMOUS CELL CARCINOMA 2 0.0002
477 GASTROINTESTINAL DISORDER 19 0.0002
478 HEPATOCELLULAR INJURY 3 0.0002
479 SINUS TACHYCARDIA 3 0.0002
480 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
481 NON-SMALL CELL LUNG CANCER 1 0.0002
482 HYPOVOLAEMIC SHOCK 1 0.0002
483 ACCIDENTAL UNDERDOSE 3 0.0002
484 ENTEROCOCCAL INFECTION 1 0.0002
485 SINUS BRADYCARDIA 2 0.0002
486 VITREOUS FLOATERS 2 0.0002
487 BODY TEMPERATURE DECREASED 2 0.0002
488 HOSPICE CARE 2 0.0002
489 RENAL IMPAIRMENT 17 0.0002
490 DIABETIC NEUROPATHY 1 0.0002
491 HEART RATE INCREASED 20 0.0002
492 PULMONARY MASS 3 0.0002
493 INABILITY TO AFFORD MEDICATION 2 0.0002
494 ABDOMINAL TENDERNESS 1 0.0002
495 HEPATIC ENZYME ABNORMAL 1 0.0002
496 RASH MACULAR 7 0.0002
497 SALIVARY HYPERSECRETION 2 0.0002
498 FLUID INTAKE REDUCED 1 0.0002
499 DERMATITIS EXFOLIATIVE 1 0.0002
500 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
501 ABDOMINAL PAIN LOWER 5 0.0002
502 RASH 86 0.0002
503 TOOTH ABSCESS 2 0.0002
504 BODY TEMPERATURE INCREASED 4 0.0002
505 AMMONIA INCREASED 1 0.0002
506 EAR DISCOMFORT 2 0.0002
507 PRODUCT COLOUR ISSUE 1 0.0002
508 ABDOMINAL PAIN UPPER 40 0.0002
509 PERIPHERAL VASCULAR DISORDER 1 0.0002
510 TEMPERATURE INTOLERANCE 2 0.0002
511 DIARRHOEA 125 0.0002
512 SKIN NECROSIS 1 0.0002
513 COUGH 54 0.0002
514 PETECHIAE 2 0.0002
515 BRAIN FOG 3 0.0002
516 DRUG-INDUCED LIVER INJURY 6 0.0002
517 DERMATITIS 4 0.0002
518 CYANOSIS 3 0.0002
519 SICKLE CELL ANAEMIA WITH CRISIS 3 0.0002
520 SCRATCH 2 0.0002
521 SERUM FERRITIN INCREASED 1 0.0002
522 PNEUMOTHORAX 3 0.0002
523 BREAST PAIN 2 0.0002
524 ANAL FISSURE 1 0.0002
525 DYSPNOEA EXERTIONAL 7 0.0002
526 MUSCLE TIGHTNESS 3 0.0002
527 DRY MOUTH 15 0.0002
528 HIP SURGERY 1 0.0002
529 FAECES DISCOLOURED 4 0.0002
530 ILLNESS 19 0.0002
531 NONSPECIFIC REACTION 1 0.0002
532 GASTROINTESTINAL PAIN 2 0.0002
533 VENTRICULAR TACHYCARDIA 3 0.0002
534 CHOKING SENSATION 1 0.0002
535 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
536 THROAT IRRITATION 8 0.0002
537 OCULAR DISCOMFORT 2 0.0002
538 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
539 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
540 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
541 CHOLECYSTITIS ACUTE 1 0.0002
542 PRODUCT AVAILABILITY ISSUE 4 0.0002
543 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
544 BLOOD URIC ACID INCREASED 1 0.0002
545 CONDITION AGGRAVATED 52 0.0002
546 HYPERCHLORHYDRIA 1 0.0002
547 DECREASED INTEREST 1 0.0002
548 BRADYKINESIA 1 0.0002
549 COVID-19 PNEUMONIA 2 0.0002
550 BACTERAEMIA 2 0.0002
551 PLEURISY 1 0.0002
552 RENAL INJURY 5 0.0002
553 GALLBLADDER DISORDER 3 0.0002
554 ADVERSE DRUG REACTION 15 0.0002
555 RESTLESS LEGS SYNDROME 3 0.0002
556 HYPOGLYCAEMIA 8 0.0002
557 HYPERGLYCAEMIA 6 0.0002
558 PRODUCT DOSE OMISSION ISSUE 48 0.0002
559 INFUSION SITE SWELLING 1 0.0002
560 INFECTION 23 0.0002
561 PHOTOPSIA 1 0.0002
562 SCREAMING 1 0.0002
563 INTRAOCULAR PRESSURE INCREASED 2 0.0002
564 PULMONARY OEDEMA 7 0.0002
565 ROTATOR CUFF SYNDROME 2 0.0002
566 GALACTORRHOEA 1 0.0002
567 DYSPNOEA 88 0.0002
568 ERUCTATION 3 0.0002
569 HIATUS HERNIA 2 0.0002
570 EAR PAIN 3 0.0002
571 PALPITATIONS 18 0.0002
572 PRURITUS 59 0.0002
573 TOOTH INFECTION 2 0.0002
574 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
575 BLOOD PRESSURE INCREASED 23 0.0002
576 PLATELET COUNT DECREASED 16 0.0001
577 MENINGITIS 1 0.0001
578 FULL BLOOD COUNT DECREASED 3 0.0001
579 METASTASES TO LYMPH NODES 1 0.0001
580 FREQUENT BOWEL MOVEMENTS 4 0.0001
581 UVEITIS 2 0.0001
582 PRODUCT LABEL ISSUE 1 0.0001
583 JOINT EFFUSION 1 0.0001
584 LARGE INTESTINE POLYP 1 0.0001
585 FEELING COLD 4 0.0001
586 PANCYTOPENIA 8 0.0001
587 THROMBOCYTOPENIA 16 0.0001
588 DEFAECATION URGENCY 1 0.0001
589 BLOOD TEST ABNORMAL 2 0.0001
590 PAIN IN JAW 4 0.0001
591 DIVERTICULUM 1 0.0001
592 RETINAL HAEMORRHAGE 1 0.0001
593 PRODUCT SUPPLY ISSUE 1 0.0001
594 PARAESTHESIA ORAL 2 0.0001
595 VISION BLURRED 19 0.0001
596 SWELLING FACE 9 0.0001
597 DERMATITIS BULLOUS 1 0.0001
598 ORAL DISORDER 1 0.0001
599 MOUTH HAEMORRHAGE 1 0.0001
600 MELAENA 3 0.0001
601 PNEUMONIA 44 0.0001
602 INFLAMMATION 7 0.0001
603 BLINDNESS TRANSIENT 1 0.0001
604 SENSITIVE SKIN 1 0.0001
605 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
606 STEVENS-JOHNSON SYNDROME 3 0.0001
607 WHEEZING 8 0.0001
608 EYE SWELLING 5 0.0001
609 ABDOMINAL DISTENSION 14 0.0001
610 CHROMATURIA 3 0.0001
611 HYPOAESTHESIA ORAL 2 0.0001
612 WEIGHT DECREASED 37 0.0001
613 ANAEMIA 25 0.0001
614 ACUTE KIDNEY INJURY 20 0.0001
615 SHOCK 3 0.0001
616 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
617 HYPOALBUMINAEMIA 1 0.0001
618 PULMONARY HAEMORRHAGE 1 0.0001
619 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
620 DISEASE PROGRESSION 15 0.0001
621 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
622 RENAL CYST 1 0.0001
623 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
624 ABSCESS 2 0.0001
625 ATRIAL FLUTTER 1 0.0001
626 DECREASED APPETITE 29 0.0001
627 MUSCLE DISORDER 1 0.0001
628 FLATULENCE 7 0.0001
629 PERIPHERAL SWELLING 19 0.0001
630 NEUTROPHIL COUNT DECREASED 5 0.0001
631 HICCUPS 1 0.0001
632 HYPERAESTHESIA 1 0.0001
633 ESCHERICHIA INFECTION 1 0.0001
634 PHOTOSENSITIVITY REACTION 2 0.0001
635 SPINAL COMPRESSION FRACTURE 1 0.0001
636 MENSTRUAL DISORDER 1 0.0001
637 TREATMENT FAILURE 10 0.0001
638 EMBOLISM 1 0.0001
639 COAGULOPATHY 2 0.0001
640 BLOOD UREA INCREASED 2 0.0001
641 CHILLS 14 0.0001
642 HALLUCINATION 9 0.0001
643 SURGERY 7 0.0001
644 OROPHARYNGEAL PAIN 11 0.0001
645 INFUSION SITE ERYTHEMA 1 0.0001
646 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
647 ANAPHYLACTIC SHOCK 3 0.0001
648 SKIN SWELLING 1 0.0001
649 HYPOXIA 4 0.0001
650 LYMPHOCYTE COUNT DECREASED 2 0.0001
651 VISUAL IMPAIRMENT 14 0.0001
652 HEAD DISCOMFORT 2 0.0001
653 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
654 ABDOMINAL PAIN 26 0.0001
655 JAUNDICE 3 0.0001
656 ANAL INCONTINENCE 1 0.0001
657 MYELOSUPPRESSION 4 0.0001
658 THROAT TIGHTNESS 3 0.0001
659 GASTROENTERITIS VIRAL 2 0.0001
660 OROPHARYNGEAL DISCOMFORT 1 0.0001
661 LEUKOCYTOSIS 2 0.0001
662 PNEUMONITIS 3 0.0001
663 LIP DRY 1 0.0001
664 CRYING 4 0.0001
665 BONE DISORDER 2 0.0001
666 RESPIRATORY FAILURE 8 0.0001
667 TREATMENT NONCOMPLIANCE 6 0.0001
668 HIDRADENITIS 1 0.0001
669 DYSURIA 4 0.0001
670 IRON DEFICIENCY ANAEMIA 1 0.0001
671 PROCEDURAL PAIN 3 0.0001
672 MENTAL STATUS CHANGES 3 0.0001
673 BACTERIAL INFECTION 2 0.0001
674 MIDDLE INSOMNIA 2 0.0001
675 HEPATIC CIRRHOSIS 2 0.0001
676 BLOOD URINE PRESENT 2 0.0001
677 DRY SKIN 14 0.0001
678 HYPERSOMNIA 3 0.0001
679 SEROTONIN SYNDROME 2 0.0001
680 HYPERCHOLESTEROLAEMIA 1 0.0001
681 ATELECTASIS 1 0.0001
682 AUTOIMMUNE DISORDER 1 0.0001
683 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
684 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
685 PHARYNGEAL SWELLING 1 0.0001
686 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
687 TACHYCARDIA 9 0.0001
688 DISORIENTATION 4 0.0001
689 HAEMATOCRIT DECREASED 2 0.0001
690 DIZZINESS 50 0.0001
691 DISCOMFORT 6 0.0001
692 SLUGGISHNESS 1 0.0001
693 FEELING HOT 6 0.0001
694 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
695 DRUG INEFFECTIVE 128 0.0001
696 POOR VENOUS ACCESS 1 0.0001
697 SWOLLEN TONGUE 3 0.0001
698 ECZEMA 5 0.0001
699 URTICARIA 16 0.0001
700 FULL BLOOD COUNT ABNORMAL 1 0.0001
701 CYSTITIS 3 0.0001
702 EATING DISORDER 2 0.0001
703 FATIGUE 73 0.0001
704 HYPERHIDROSIS 12 0.0001
705 DECREASED ACTIVITY 1 0.0001
706 ATRIAL FIBRILLATION 9 0.0001
707 PHARYNGITIS STREPTOCOCCAL 1 0.0001
708 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
709 MENTAL DISORDER 4 0.0001
710 OESOPHAGITIS 1 0.0001
711 PYREXIA 31 0.0001
712 MALNUTRITION 1 0.0001
713 ORAL PAIN 2 0.0001
714 EYE PRURITUS 3 0.0001
715 NEPHROPATHY TOXIC 1 0.0001
716 FISTULA 1 0.0001
717 BLOOD CALCIUM DECREASED 1 0.0001
718 MALAISE 39 0.0001
719 REBOUND EFFECT 1 0.0001
720 MITRAL VALVE INCOMPETENCE 1 0.0001
721 HEADACHE 55 0.0001
722 DERMATITIS CONTACT 1 0.0001
723 HAEMOGLOBIN DECREASED 9 0.0001
724 NEPHROLITHIASIS 4 0.0001
725 HYPOAESTHESIA 13 0.0001
726 MUSCLE TWITCHING 2 0.0001
727 HYPOKALAEMIA 4 0.0001
728 SEIZURE 10 0.0001
729 PERICARDIAL EFFUSION 2 0.0001
730 ELECTROLYTE IMBALANCE 1 0.0001
731 HEART RATE DECREASED 3 0.0001
732 BLOOD IRON DECREASED 1 0.0001
733 CATARACT 5 0.0001
734 MACULAR DEGENERATION 1 0.0001
735 HYPERLIPIDAEMIA 1 0.0001
736 DEATH 72 0.0001
737 POLYNEUROPATHY 1 0.0001
738 SKIN EXFOLIATION 7 0.0001
739 INSOMNIA 22 0.0001
740 CONSTIPATION 18 0.0001
741 FIBROMYALGIA 2 0.0001
742 PRESYNCOPE 2 0.0001
743 UNDERDOSE 6 0.0001
744 VERTIGO 5 0.0001
745 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
746 DYSPEPSIA 8 0.0001
747 CYST 1 0.0001
748 CONFUSIONAL STATE 13 0.0001
749 PNEUMONIA ASPIRATION 2 0.0001
750 MUSCLE ATROPHY 1 0.0001
751 CARDIOVASCULAR DISORDER 2 0.0001
752 TREMOR 13 0.0001
753 SINUSITIS 8 0.0001
754 THERAPY CESSATION 4 0.0001
755 AMNESIA 5 0.0001
756 RESPIRATORY TRACT INFECTION 2 0.0001
757 PLATELET COUNT INCREASED 1 0.0001
758 NODULE 1 0.0001
759 NERVOUSNESS 4 0.0001
760 HAND DEFORMITY 1 0.0001
761 GASTRITIS 2 0.0001
762 ORAL CANDIDIASIS 1 0.0001
763 PANCREATITIS 4 0.0001
764 FEELING ABNORMAL 18 0.0001
765 DEHYDRATION 10 0.0001
766 EYE HAEMORRHAGE 1 0.0001
767 HAIR TEXTURE ABNORMAL 1 0.0001
768 QUALITY OF LIFE DECREASED 1 0.0001
769 FEAR 2 0.0001
770 PAIN OF SKIN 2 0.0001
771 LIMB INJURY 2 0.0001
772 ACUTE HEPATIC FAILURE 1 0.0001
773 RESPIRATORY ARREST 2 0.0001
774 ABNORMAL DREAMS 2 0.0001
775 ANAPHYLACTIC REACTION 4 0.0001
776 DIVERTICULITIS 2 0.0001
777 POLLAKIURIA 3 0.0001
778 WOUND 2 0.0001
779 BLINDNESS UNILATERAL 1 0.0001
780 SEASONAL ALLERGY 1 0.0001
781 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
782 RED BLOOD CELL COUNT DECREASED 2 0.0001
783 PARAESTHESIA 11 0.0001
784 IMPAIRED QUALITY OF LIFE 1 0.0001
785 LETHARGY 4 0.0001
786 BALANCE DISORDER 6 0.0001
787 SEPTIC SHOCK 3 0.0001
788 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
789 ERYTHEMA 14 0.0001
790 NASAL CONGESTION 4 0.0001
791 ACUTE MYOCARDIAL INFARCTION 2 0.0001
792 LABORATORY TEST ABNORMAL 2 0.0001
793 COLITIS ULCERATIVE 3 0.0001
794 IMMUNODEFICIENCY 1 0.0001
795 DEVICE ISSUE 6 0.0001
796 EPISTAXIS 5 0.0001
797 THERAPY NON-RESPONDER 3 0.0001
798 ASTHENIA 25 0.0001
799 HOT FLUSH 5 0.0001
800 APHASIA 2 0.0001
801 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
802 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
803 STOMATITIS 4 0.0001
804 DEVICE RELATED INFECTION 1 0.0001
805 LIMB DISCOMFORT 2 0.0001
806 MUSCULOSKELETAL CHEST PAIN 1 0.0001
807 DELUSION 1 0.0001
808 EJECTION FRACTION DECREASED 1 0.0001
809 DRUG DOSE OMISSION BY DEVICE 5 0.0001
810 ARRHYTHMIA 3 0.0001
811 CARDIAC FAILURE 5 0.0001
812 RHINORRHOEA 4 0.0001
813 BLOOD POTASSIUM INCREASED 1 0.0001
814 DRUG LEVEL INCREASED 1 0.0001
815 RENAL FAILURE 8 0.0001
816 DRY EYE 3 0.0001
817 SYNCOPE 6 0.0001
818 SKIN DISORDER 2 0.0001
819 CHEST PAIN 11 0.0001
820 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
821 FLUID RETENTION 3 0.0001
822 NEUTROPENIA 8 0.0001
823 CIRCULATORY COLLAPSE 1 0.0001
824 METRORRHAGIA 1 0.0001
825 HAEMATURIA 2 0.0001
826 NIGHTMARE 2 0.0001
827 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
828 COVID-19 10 0.0001
829 COLD SWEAT 1 0.0001
830 DRUG INTERACTION 9 0.0001
831 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
832 GOUT 1 0.0001
833 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
834 OEDEMA 3 0.0001
835 C-REACTIVE PROTEIN INCREASED 2 0.0001
836 END STAGE RENAL DISEASE 1 0.0001
837 CONJUNCTIVITIS 1 0.0001
838 SEPSIS 6 0.0001
839 HEPATIC STEATOSIS 1 0.0001
840 NECK PAIN 3 0.0001
841 SWELLING 5 0.0001
842 DYSARTHRIA 2 0.0001
843 ASTHMA 6 0.0001
844 INTESTINAL OBSTRUCTION 2 0.0001
845 MYALGIA 9 0.0001
846 HYPOCALCAEMIA 1 0.0001
847 FRACTURE 1 0.0001
848 FOOT FRACTURE 1 0.0001
849 DYSPHAGIA 5 0.0001
850 GASTRIC ULCER 1 0.0001
851 FEELING JITTERY 1 0.0001
852 SLEEP APNOEA SYNDROME 1 0.0001
853 HERPES ZOSTER 3 0.0001
854 CONTUSION 5 0.0001
855 GLAUCOMA 1 0.0001
856 CHOKING 1 0.0001
857 BLOOD PRESSURE ABNORMAL 1 0.0001
858 SPINAL FRACTURE 1 0.0000
859 JOINT SWELLING 6 0.0000
860 FEEDING DISORDER 1 0.0000
861 PLEURAL EFFUSION 3 0.0000
862 RIB FRACTURE 1 0.0000
863 PULMONARY HYPERTENSION 1 0.0000
864 CARDIO-RESPIRATORY ARREST 2 0.0000
865 MOUTH ULCERATION 1 0.0000
866 HALLUCINATION, VISUAL 1 0.0000
867 OSTEOARTHRITIS 2 0.0000
868 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
869 DEVICE LEAKAGE 2 0.0000
870 VAGINAL HAEMORRHAGE 2 0.0000
871 ANGIOEDEMA 2 0.0000
872 BLOOD PRESSURE DECREASED 3 0.0000
873 LIVER DISORDER 2 0.0000
874 GLOSSODYNIA 1 0.0000
875 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
876 SNEEZING 1 0.0000
877 HEART RATE IRREGULAR 1 0.0000
878 MUSCULAR WEAKNESS 5 0.0000
879 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
880 RENAL DISORDER 2 0.0000
881 BURNING SENSATION 3 0.0000
882 PRODUCT USE ISSUE 8 0.0000
883 ANXIETY 12 0.0000
884 PULMONARY EMBOLISM 4 0.0000
885 DISEASE RECURRENCE 2 0.0000
886 PRODUCT PRESCRIBING ERROR 1 0.0000
887 MIGRAINE 4 0.0000
888 NEURALGIA 1 0.0000
889 URINARY TRACT INFECTION 7 0.0000
890 OEDEMA PERIPHERAL 5 0.0000
891 ENCEPHALOPATHY 1 0.0000
892 EXTRAPYRAMIDAL DISORDER 1 0.0000
893 HYPOTENSION 8 0.0000
894 SOMNOLENCE 8 0.0000
895 CHRONIC KIDNEY DISEASE 3 0.0000
896 HAEMATEMESIS 1 0.0000
897 HYPOPHAGIA 1 0.0000
898 HAEMATOMA 1 0.0000
899 DIPLOPIA 1 0.0000
900 SPEECH DISORDER 2 0.0000
901 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
902 MUSCLE SPASMS 7 0.0000
903 ANHEDONIA 1 0.0000
904 HYPERTENSION 8 0.0000
905 BRADYCARDIA 2 0.0000
906 EAR INFECTION 1 0.0000
907 CARDIAC FAILURE CONGESTIVE 3 0.0000
908 THROMBOSIS 3 0.0000
909 BLOOD GLUCOSE INCREASED 7 0.0000
910 PALLOR 1 0.0000
911 GAIT DISTURBANCE 7 0.0000
912 CARDIAC ARREST 3 0.0000
913 RESPIRATORY DISTRESS 1 0.0000
914 ARTHROPATHY 2 0.0000
915 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
916 DEMENTIA 1 0.0000
917 EYE PAIN 2 0.0000
918 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
919 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
920 ANGINA PECTORIS 1 0.0000
921 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
922 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
923 BACK PAIN 8 0.0000
924 LIVER FUNCTION TEST ABNORMAL 1 0.0000
925 MUSCULOSKELETAL STIFFNESS 3 0.0000
926 BONE PAIN 2 0.0000
927 ASCITES 1 0.0000
928 PAIN IN EXTREMITY 10 0.0000
929 PSYCHOTIC DISORDER 1 0.0000
930 IRRITABILITY 2 0.0000
931 BLOOD POTASSIUM DECREASED 1 0.0000
932 HEPATIC FAILURE 1 0.0000
933 ILL-DEFINED DISORDER 2 0.0000
934 INJECTION SITE RASH 1 0.0000
935 ADVERSE EVENT 3 0.0000
936 FEMUR FRACTURE 1 0.0000
937 CARDIAC DISORDER 3 0.0000
938 NERVOUS SYSTEM DISORDER 1 0.0000
939 METABOLIC ACIDOSIS 1 0.0000
940 LOSS OF CONSCIOUSNESS 4 0.0000
941 MOVEMENT DISORDER 1 0.0000
942 LACTIC ACIDOSIS 1 0.0000
943 DEEP VEIN THROMBOSIS 2 0.0000
944 DEPRESSION 7 0.0000
945 CHOLELITHIASIS 1 0.0000
946 IMPAIRED HEALING 1 0.0000
947 INFUSION RELATED REACTION 2 0.0000
948 FEBRILE NEUTROPENIA 2 0.0000
949 GAIT INABILITY 1 0.0000
950 INJECTION SITE PRURITUS 2 0.0000
951 PAIN 18 0.0000
952 DELIRIUM 1 0.0000
953 DEVICE USE ERROR 1 0.0000
954 MYOCARDIAL INFARCTION 5 0.0000
955 HYPERKALAEMIA 1 0.0000
956 NO ADVERSE EVENT 5 0.0000
957 PANIC ATTACK 1 0.0000
958 NASOPHARYNGITIS 5 0.0000
959 ACNE 2 0.0000
960 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
961 ABNORMAL BEHAVIOUR 1 0.0000
962 DYSKINESIA 1 0.0000
963 BLINDNESS 1 0.0000
964 INFLUENZA LIKE ILLNESS 2 0.0000
965 PRODUCT STORAGE ERROR 2 0.0000
966 INTENTIONAL PRODUCT MISUSE 2 0.0000
967 WEIGHT INCREASED 5 0.0000
968 SUICIDAL IDEATION 2 0.0000
969 COGNITIVE DISORDER 1 0.0000
970 COMA 1 0.0000
971 BLOOD GLUCOSE DECREASED 1 0.0000
972 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
973 AGGRESSION 1 0.0000
974 FLUSHING 2 0.0000
975 HAEMORRHAGE 2 0.0000
976 DEPRESSED MOOD 1 0.0000
977 DISTURBANCE IN ATTENTION 1 0.0000
978 HAEMATOCHEZIA 1 0.0000
979 FALL 6 0.0000
980 INFLUENZA 2 0.0000
981 RHEUMATOID ARTHRITIS 2 0.0000
982 ARTHRALGIA 7 0.0000
983 ALOPECIA 3 0.0000
984 MEMORY IMPAIRMENT 2 0.0000
985 MOBILITY DECREASED 1 0.0000
986 AGITATION 1 0.0000
987 BRONCHITIS 1 0.0000
988 TOXICITY TO VARIOUS AGENTS 2 0.0000
989 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
990 INJECTION SITE PAIN 3 0.0000
991 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
992 OVERDOSE 2 0.0000
993 CEREBROVASCULAR ACCIDENT 1 0.0000